We have a range of generic and branded medicines used in the management of women's health conditions.
We focus on supporting healthcare professionals and women in the UK in managing conditions related to women’s health such as infertility and contraception.
Our aim is to work in partnership to develop joined-up care through Joint Working projects, to improve patient outcomes and enhance patient experience, and also to offer value for money. That might be through medicines optimisation, quality improvement, pathway redesign or improvement, innovation or identifying cost efficiencies.
Statistics suggest around one in seven couples may have difficulty conceiving. This is approximately 3.5 million people in the UK.1 We believe we’re well placed to support healthcare professionals dealing with an array of women’s health issues that they may come into contact with.
Our portfolio includes a variety of therapeutic options, comprising both generic and branded medicines, in addition to Ovaleap®▼ (follitropin alfa) for women undergoing assisted reproductive technology.
Our Joint Working projects help the NHS and healthcare professionals deliver improved patient outcomes. Our Joint Working projects are available on our Joint Working pages.
To discuss potential Joint Working opportunities with Teva within women's health you can contact us and a representative from Teva will be in touch.
1 http://www.nhs.uk/conditions/infertility/pages/introduction.aspx [accessed 23.03.16].
2 Ovaleap® (follitropin alfa) Summary of Product Characteristics.
To access this section of the Teva UK Limited website you need to be a member of the healthcare profession
because the materials included in this area of our website are specifically prepared for that audience
To understand why that is - please visit: Working in a regulated environment
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.